• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受免疫检查点抑制剂治疗的肺癌患者的免疫基因网络

Immune Gene Networks from Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

作者信息

Kim Kyung Soo, Kang Taewon, Jekarl Dong Wook

机构信息

Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

出版信息

Biomedicines. 2024 Mar 12;12(3):628. doi: 10.3390/biomedicines12030628.

DOI:10.3390/biomedicines12030628
PMID:38540240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10968332/
Abstract

The association between immune checkpoint inhibitors (ICIs) and immune gene networks in squamous lung cancer (LUSC) and lung adenocarcinoma (LUAD) was studied. Immune gene networks were constructed using RNA-seq data from the gene expression omnibus (GEO) database. Datasets with more than 10 samples of normal control and tumor tissues were selected; of these, GSE87340, GSE120622, and GSE111907 were suitable for analysis. Gene set enrichment for pathway analysis was performed. For immune gene network construction, 998 unique immune genes were selected from 21 pathways in the Kyoto Encyclopedia of Genes and Genomes (KEGG). Gene function annotation was performed based on the KEGG, Gene Ontology, and Reactome databases. Tumor tissues showed decreased coagulation, hematopoiesis, and innate immune pathways, whereas complement- and coagulation-related genes were prominent in the tumor immune gene network. The average numbers of neighbors, clustering coefficients, network diameters, path lengths, densities, and heterogeneities were highest for normal tissue, followed by LUAD and LUSC. Decreased coagulation genes, which were prominent in tumor immune networks, imply functional attenuation. LUAD was deviated from normal tissue, based on network parameters. Tumor tissues showed decreased immune function, and the deviation of LUSC from normal tissue might explain LUSC's better therapeutic response to ICI treatment.

摘要

研究了免疫检查点抑制剂(ICI)与肺鳞状细胞癌(LUSC)和肺腺癌(LUAD)中免疫基因网络之间的关联。利用来自基因表达综合数据库(GEO)的RNA测序数据构建免疫基因网络。选择正常对照和肿瘤组织样本数超过10个的数据集;其中,GSE87340、GSE120622和GSE111907适合进行分析。进行基因集富集以进行通路分析。对于免疫基因网络构建,从京都基因与基因组百科全书(KEGG)的21条通路中选择了998个独特的免疫基因。基于KEGG、基因本体论和Reactome数据库进行基因功能注释。肿瘤组织显示凝血、造血和固有免疫通路减少,而补体和凝血相关基因在肿瘤免疫基因网络中突出。正常组织的邻居平均数、聚类系数、网络直径、路径长度、密度和异质性最高,其次是LUAD和LUSC。在肿瘤免疫网络中突出的凝血基因减少意味着功能衰减。基于网络参数,LUAD偏离正常组织。肿瘤组织显示免疫功能降低,LUSC与正常组织的偏差可能解释了LUSC对ICI治疗更好的治疗反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/eb88c0e17053/biomedicines-12-00628-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/524183675eb1/biomedicines-12-00628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/cdbb1272cf90/biomedicines-12-00628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/0ff00b64464c/biomedicines-12-00628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/42d40fbf7714/biomedicines-12-00628-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/eb88c0e17053/biomedicines-12-00628-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/524183675eb1/biomedicines-12-00628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/cdbb1272cf90/biomedicines-12-00628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/0ff00b64464c/biomedicines-12-00628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/42d40fbf7714/biomedicines-12-00628-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe9/10968332/eb88c0e17053/biomedicines-12-00628-g005.jpg

相似文献

1
Immune Gene Networks from Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.接受免疫检查点抑制剂治疗的肺癌患者的免疫基因网络
Biomedicines. 2024 Mar 12;12(3):628. doi: 10.3390/biomedicines12030628.
2
Immune gene expression networks in sepsis: A network biology approach.脓毒症中的免疫基因表达网络:一种网络生物学方法。
PLoS One. 2021 Mar 5;16(3):e0247669. doi: 10.1371/journal.pone.0247669. eCollection 2021.
3
serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism.作为肺腺癌的一种预后生物标志物,在RNA表观遗传修饰、DNA损伤修复(DDR)途径和RNA代谢中具有重要意义。
Front Oncol. 2023 Dec 13;13:1274439. doi: 10.3389/fonc.2023.1274439. eCollection 2023.
4
[Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].泛素特异性蛋白酶7的泛癌分析及其在瘢痕溃疡癌变中的表达变化
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Jun 20;39(6):518-526. doi: 10.3760/cma.j.cn501225-20230421-00137.
5
Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.探索并比较肺腺癌和肺鳞癌之间的基因表达和甲基化差异。
J Cell Physiol. 2019 Apr;234(4):4454-4459. doi: 10.1002/jcp.27240. Epub 2018 Oct 14.
6
Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.基于生物信息学的肺癌潜在关键基因和预后生物标志物的鉴定。
Biomed Res Int. 2023 Jan 18;2023:2152432. doi: 10.1155/2023/2152432. eCollection 2023.
7
Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.基于细胞焦亡相关基因预测肺鳞癌免疫微环境及免疫治疗效果。
Medicine (Baltimore). 2022 Sep 16;101(37):e30304. doi: 10.1097/MD.0000000000030304.
8
Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.鉴定SHCBP1作为一种潜在的生物标志物,涉及多种癌症的诊断、预后及肿瘤免疫微环境。
Comput Struct Biotechnol J. 2022 Jun 18;20:3106-3119. doi: 10.1016/j.csbj.2022.06.039. eCollection 2022.
9
Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.基于癌症干性的肺腺癌和肺鳞癌预后免疫相关基因特征。
Front Endocrinol (Lausanne). 2021 Oct 21;12:755805. doi: 10.3389/fendo.2021.755805. eCollection 2021.
10
Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.通过 RT-qPCR、TCGA 和计算机分析分析肺腺癌中 HOXA3 的下调及其相关分子机制。
Int J Oncol. 2018 Oct;53(4):1557-1579. doi: 10.3892/ijo.2018.4508. Epub 2018 Jul 30.

引用本文的文献

1
Alterations in RNA Expression Profile Following and Inoculation into Platelet Concentrates.接种到血小板浓缩物中后RNA表达谱的变化。
Int J Mol Sci. 2025 Mar 26;26(7):3009. doi: 10.3390/ijms26073009.

本文引用的文献

1
Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.在 cBioPortal 中分析和可视化 AACR 项目 GENIE 生物制药协作的纵向基因组和临床数据。
Cancer Res. 2023 Dec 1;83(23):3861-3867. doi: 10.1158/0008-5472.CAN-23-0816.
2
Metabolic profiles of lung adenocarcinoma via peripheral blood and diagnostic model construction.通过外周血构建肺腺癌代谢特征及诊断模型。
Sci Rep. 2023 May 5;13(1):7304. doi: 10.1038/s41598-023-34575-0.
3
The Gene Ontology knowledgebase in 2023.
2023 版基因本体论知识库。
Genetics. 2023 May 4;224(1). doi: 10.1093/genetics/iyad031.
4
Cytoscape.js 2023 update: a graph theory library for visualization and analysis.Cytoscape.js 2023 更新:用于可视化和分析的图论库。
Bioinformatics. 2023 Jan 1;39(1). doi: 10.1093/bioinformatics/btad031.
5
Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis.组织学对晚期非小细胞肺癌免疫检查点抑制剂疗效的影响:一项系统评价和荟萃分析。
Front Oncol. 2022 Nov 10;12:968517. doi: 10.3389/fonc.2022.968517. eCollection 2022.
6
Immune checkpoint inhibitors alone vs immune checkpoint inhibitors-combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis.免疫检查点抑制剂单药与免疫检查点抑制剂联合化疗治疗高 PD-L1 表达 NSCLC 患者:一项网络荟萃分析。
Br J Cancer. 2022 Sep;127(5):948-956. doi: 10.1038/s41416-022-01832-4. Epub 2022 May 31.
7
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.新辅助纳武利尤单抗联合化疗治疗可切除肺癌。
N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11.
8
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects.免疫检查点抑制剂在非小细胞肺癌中的应用:进展、挑战与展望。
Cells. 2022 Jan 19;11(3):320. doi: 10.3390/cells11030320.
9
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
10
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8 T cell clone size and cytotoxicity.免疫检查点阻断敏感性和无进展生存期与基线 CD8 T 细胞克隆大小和细胞毒性相关。
Sci Immunol. 2021 Oct;6(64):eabj8825. doi: 10.1126/sciimmunol.abj8825. Epub 2021 Oct 1.